Scholarlink

Invega Sustenna® is the first long-acting injectable (LAI) paliperidone injection. Paliperidone, the active metabolite of risperidone, was the seventh second-generation antipsychotic available on the United States market. This chapter provides clinical pearls on how to appropriately prescribe and administer Invega Sustenna®.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Paliperidone Palmitate (Invega Sustenna®): Second-Generation Antipsychotic Long-Acting Injectable

  • 章节

  • 发表日期：

    2025年

查看全文
  • Megan J. Ehret

摘要

Invega Sustenna® is the first long-acting injectable (LAI) paliperidone injection. Paliperidone, the active metabolite of risperidone, was the seventh second-generation antipsychotic available on the United States market. This chapter provides clinical pearls on how to appropriately prescribe and administer Invega Sustenna®.